SCIENTURE HOLDINGS, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
SCIENTURE HOLDINGS, INC. (SCNX) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $20.89 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $7.22K, a 51.69% decline year-over-year.
- SCIENTURE HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $13.67K, a 5.90% decline year-over-year.
- SCIENTURE HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $6.45K, a 70.17% decline year-over-year.
- SCIENTURE HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $35.94K, a 30.03% decline from fiscal 2024.
- SCIENTURE HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $51.36K, a 76.18% decline from fiscal 2023.
- SCIENTURE HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $215.66K, a 19.01% increase from fiscal 2022.
- SCIENTURE HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $181.22K, a 37.75% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $20.89K 10-Q · filed 2026-08-13 | $20.89K derived: sum of 3 quarters · filed 2026-08-13 | $27.35K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $13.67K 10-Q · filed 2026-05-15 | $13.67K derived: sum of 2 quarters · filed 2026-05-15 | $20.12K derived: sum of 3 quarters · filed 2026-05-15 | $35.08K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $6.45K derived: sum of 2 quarters · filed 2026-03-30 | $21.41K derived: sum of 3 quarters · filed 2026-08-13 | $35.94K 10-K · filed 2026-03-30 |
| 2025-09-30 | $6.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $21.41K derived: sum of 2 quarters · filed 2026-08-13 | $35.94K 10-Q · filed 2025-11-12 | $49.99K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $14.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $29.48K 10-Q · filed 2026-08-13 | $43.54K derived: sum of 3 quarters · filed 2026-08-13 | $65.18K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $14.52K 10-Q · filed 2026-05-15 | $28.58K derived: sum of 2 quarters · filed 2026-05-15 | $50.22K derived: sum of 3 quarters · filed 2026-05-15 | $58.08K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $14.06K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $35.70K derived: sum of 2 quarters · filed 2026-03-30 | $43.56K derived: sum of 3 quarters · filed 2026-03-30 | $51.36K 10-K · filed 2026-03-30 |
| 2024-09-30 | $21.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $29.50K derived: sum of 2 quarters · filed 2025-11-12 | $37.30K 10-Q · filed 2025-11-12 | -$72.95K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $7.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $15.67K 10-Q · filed 2025-08-12 | -$94.58K derived: sum of 3 quarters · filed 2025-08-12 | $131.13K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $7.80K 10-Q · filed 2025-05-12 | -$102.45K derived: sum of 2 quarters · filed 2025-05-12 | $123.27K derived: sum of 3 quarters · filed 2025-05-12 | $173.97K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$110.25K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $115.47K derived: sum of 2 quarters · filed 2025-03-26 | $166.17K derived: sum of 3 quarters · filed 2025-03-26 | $215.66K 10-K · filed 2025-03-26 |
| 2023-09-30 | $225.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $276.42K derived: sum of 2 quarters · filed 2024-11-06 | $325.92K 10-Q · filed 2024-11-06 | $374.29K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $50.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $100.20K 10-Q · filed 2024-08-09 | $148.57K derived: sum of 3 quarters · filed 2024-08-09 | $195.60K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $49.50K 10-Q · filed 2024-06-26 | $97.87K derived: sum of 2 quarters · filed 2024-06-26 | $144.91K derived: sum of 3 quarters · filed 2024-06-26 | $176.39K derived: sum of 4 quarters · filed 2024-06-26 |
| 2022-12-31 | $48.37K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | $95.41K derived: sum of 2 quarters · filed 2024-04-22 | $126.89K derived: sum of 3 quarters · filed 2024-04-22 | $181.22K 10-K · filed 2024-04-22 |
| 2022-09-30 | $47.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $78.52K derived: sum of 2 quarters · filed 2023-08-18 | $132.85K 10-Q · filed 2022-11-07 | $166.97K derived: sum of 4 quarters · filed 2023-08-18 |
| 2022-06-30 | $31.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-18 | $85.81K 10-Q · filed 2023-08-18 | $119.93K derived: sum of 3 quarters · filed 2023-08-18 | $153.22K derived: sum of 4 quarters · filed 2023-08-18 |
| 2022-03-31 | $54.33K 10-Q · filed 2023-05-15 | $88.45K derived: sum of 2 quarters · filed 2023-05-15 | $121.74K derived: sum of 3 quarters · filed 2023-05-15 | $154.21K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $34.12K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $67.41K derived: sum of 2 quarters · filed 2023-03-27 | $99.88K derived: sum of 3 quarters · filed 2023-03-27 | $131.56K 10-K · filed 2023-03-27 |
| 2021-09-30 | $33.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $65.76K derived: sum of 2 quarters · filed 2022-11-07 | $97.44K 10-Q · filed 2022-11-07 | $133.86K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $32.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-25 | $64.15K 10-Q · filed 2022-07-25 | $100.57K derived: sum of 3 quarters · filed 2022-07-25 | $113.37K derived: sum of 4 quarters · filed 2022-07-25 |
| 2021-03-31 | $31.68K 10-Q · filed 2022-05-09 | $68.10K derived: sum of 2 quarters · filed 2022-05-09 | $80.90K derived: sum of 3 quarters · filed 2022-05-09 | $105.06K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $36.42K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $49.22K derived: sum of 2 quarters · filed 2022-03-28 | $73.39K derived: sum of 3 quarters · filed 2022-03-28 | $97.02K 10-K · filed 2022-03-28 |
| 2020-09-30 | $12.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-25 | $36.97K derived: sum of 2 quarters · filed 2021-10-25 | $60.60K 10-Q · filed 2021-10-25 | $83.73K derived: sum of 4 quarters · filed 2021-10-25 |
| 2020-06-30 | $24.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-26 | $47.80K 10-Q · filed 2021-07-26 | $70.93K derived: sum of 3 quarters · filed 2021-07-26 | $93.59K derived: sum of 4 quarters · filed 2021-07-26 |
| 2020-03-31 | $23.64K 10-Q · filed 2021-04-26 | $46.77K derived: sum of 2 quarters · filed 2021-04-26 | $69.43K derived: sum of 3 quarters · filed 2021-04-26 | $91.62K derived: sum of 4 quarters · filed 2021-04-26 |
| 2019-12-31 | $23.13K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $45.79K derived: sum of 2 quarters · filed 2021-03-29 | $67.99K derived: sum of 3 quarters · filed 2021-03-29 | $89.73K 10-K · filed 2021-03-29 |
| 2019-09-30 | $22.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $44.85K derived: sum of 2 quarters · filed 2020-10-26 | $66.60K 10-Q · filed 2020-10-26 | |
| 2019-06-30 | $22.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $43.94K 10-Q · filed 2020-07-27 | ||
| 2019-03-31 | $21.74K 10-Q · filed 2020-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |